Patient navigation program for cervical cancer screening in Senegal
Official title: Adaptation and Implementation of a Patient Navigation Program for Cervical Cancer Screening Across Contexts in Senegal
Run by University of Illinois Chicago · NCT05544084 · Data updated 2026-11-12
This study is testing a new support program to help women in Senegal get screened for cervical cancer and access treatment more easily.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 25 Years to 69 Years |
| Sex | All |
| Enrollment | 901 (estimated) |
| Sponsor | University of Illinois Chicago Academic / other |
| Locations | 1 site (Dakar) |
| Status | Recruiting |
| Started | August 1, 2023 |
| Main results expected | March 30, 2027 |
| Study ends | August 28, 2027 |
| Registry record updated | May 8, 2026 |
| Trial ID | NCT05544084 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include Senegalese citizens aged 25 to 69 who are willing to participate in survey assessments and seek cervical cancer prevention services.
✕Probably not a fit
Patients who are not citizens of Senegal or those outside the specified age range may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to prevent cervical cancer deaths in Senegal by addressing barriers to screening and treatment among women. Using a mixed methods approach, the study will adapt an evidence-based patient navigation program to fit both urban and rural contexts in Senegal. The Dynamic Adaptation Process will be employed to evaluate the program's effectiveness and implementation outcomes. The study will involve a stepped-wedge randomized pragmatic trial to assess the impact of navigation services on screening rates and treatment access.
Why it matters
Potential benefit: If successful, this program could significantly increase cervical cancer screening rates and improve treatment access for women in Senegal.
How similar studies have gone: Other studies have shown success with patient navigation programs in improving cancer screening rates, indicating a promising approach for this context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: The inclusion criteria for samples a, b, \& c are as follows: 1\) Senegal citizen between the ages of 25 and 69, 2) willing to participate in survey assessments; The additional criteria apply for both women and men for the follow samples: Sample a: 3) an invited member of the study National Advisory Board or Regional Implementation Resource Teams as defined above; 4) able to read and write in French. Sample b: 3) employed by the state at a study site health facility as a patient navigator, clinician (nurse, midwife) who treats and educates patients, or is a community health worker at the facility or community level (Bajenu Gox - women's health educator). Sample c: Women: 3) a woman living with a male partner who also agrees to participate in the study, 4) eligible to seek cervical cancer prevention services at a designated health facility in Senegal. Men: 3) a man living in a household with at least one woman eligible to seek cervical cancer prevention services at a designated health facility in Senegal. Exclusion Criteria: * No additional exclusion criteria exist.
Where it's running
-
University of Cheikh Anta Diop, Institute of Health and Development
Dakar, Senegal Recruiting
Study contacts
- Principal investigator: Jon A Dykens, MD, MPH — University of Illinois Chicago
- Study coordinator: Jon A Dykens, MD, MPH
- Email: jdykens@uic.edu
- Phone: 573-355-0452
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cervical screening and care options for women living with HIV who test positive for high-risk HPV
This study tests different ways to screen and manage high-risk HPV in women with HIV to see what might work best for them.
-
Hydrogel spacer to protect the rectum during cervical cancer radiotherapy
This study tests whether placing an absorbable hydrogel spacer between the cervix/vagina and rectum before definitive radiotherapy can reduce rectal radiation exposure for women with cervical cancer.
-
How cinema sessions during chemotherapy might help cervical cancer patients
We’re testing if watching films during chemotherapy helps cervical cancer patients feel less anxious and improve quality of life.
-
One-Finger Technique to identify the left upper ureter during para-aortic lymphadenectomy
This study tests a new surgical method to help surgeons find the left upper ureter during open para-aortic lymphadenectomy in women with gynecologic cancers.
-
Radiotherapy for gynecologic cancer with up to 10 metastatic sites
This registry follows adults with gynecologic cancer who have 1 to 10 active metastatic lesions and are treated with radiotherapy as part of routine care to see how such treatments work in real-world settings.
-
Stellate ganglion block and dexmedetomidine for better sleep after gynecologic laparoscopy
The study tests whether giving a preoperative stellate ganglion block plus intraoperative dexmedetomidine improves sleep after laparoscopic gynecologic surgery in women.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.